Growth Private Equity: Upside Potential of Venture Capital with A Downside Cushion
Growth Equity has emerged as a standout investment strategy, surpassing both traditional buyout and venture capital methods in performance over the past decade. Offering a unique blend of upside potential and downside protection, it has attracted investors seeking a balanced risk-return profile.
Distinguished by its focus on accelerating revenue growth and operational enhancements, Growth Equity provides a targeted approach to investing in companies with significant growth opportunities. This strategy, characterized by minimal reliance on leverage, allows investors to navigate market cycles effectively while capitalizing on emerging trends and opportunities in the private equity landscape.
Access the full report now to delve deeper into the potential of Growth Equity as a resilient investment strategy offering robust returns and balanced risk exposure in today's dynamic market environment.
If you do not have a work email address, please email us at info@primealpha.com and we can email you the report directly.
Table of Contents
Introduction to Growth Private Equity
Key Takeaways
Growth Equity Better Risk Adjusted Return Profile
Growth Equity Sweet Spot
Portfolio Company Characteristics Table
Portfolio Company Risk Profile Table
Portfolio Company Life-Cycle
VC Type Exposure With Little or No Tech Risk
Gap between Growth Equity and buyouts
We Are In Late-Stages of Economic Growth Cycle
OECD Interim Economic Growth (%) Outlook projections
The Opportunity Now – Upside Potential With a Downside Cushion
Average Annual Revenue Growth Rate (%) of companies
Thanks to our Contributor
Arcis Capital Partners LLC (“ArcisCap”) is sponsoring Arcis Technology Growth Fund LLC that invests in US technology companies with proven business models that are poised to grow – companies that we believe can meaningfully benefit from our approach of “Growth Engineering” to produce transformative change and accelerated growth in both the U.S. and Asia.
ArcisCap team is deeply rooted in global growth and performance transformation – strategic, financial, operational and technological. The team consists of globally experienced operators and investors, advisors and strategists, bankers and deal makers, and entrepreneurs. The team has differentiated experience across healthcare, digital technologies and cleantech.
The objective of the ArcisCap approach is to position our companies for an expedited exit. ArcisCap does not commit to any investment without first developing a clear roadmap for growth and identifying targeted paths to exit.
ArcisCap has already secured several exclusive investment opportunities and curated numerous opportunities, many with asymmetric global growth potential.
The firm is headquartered in New York City with offices and partner presence in Atlanta, Cambridge, Orlando, Beijing, Shanghai and Hong Kong.